Breaking News Instant updates and real-time market news.

OPXA

Opexa Therapeutics

$0.91

-0.143 (-13.62%)

07:36
11/25/16
11/25
07:36
11/25/16
07:36

Opexa reports Merck Serono not exercising option to buy Tcelna license

In a regulatory filing, Opexa Therapeutics (OPXA) reported that it received notice from Ares Trading, a wholly owned subsidiary of Merck Serono, that Merck Serono would not be exercising its option to acquire the exclusive, worldwide ex. Japan license to the company's Tcelna program for the treatment of multiple sclerosis granted to Merck Serono under the Option and License Agreement dated February 4, 2013, as amended. As a result of receiving the notice from Merck Serono, the agreement automatically expired upon receipt. As previously announced on October 28, 2016, the company's Phase IIb Abili-T clinical trial designed to evaluate the efficacy and safety of Tcelna in patients with secondary progressive MS did not meet its primary or secondary endpoints.

OPXA Opexa Therapeutics
$0.91

-0.143 (-13.62%)

11/25/15
MAXM
11/25/15
NO CHANGE
MAXM
Opexa Therapeutics mentioned positively at Maxim
06/10/16
MAXM
06/10/16
NO CHANGE
MAXM
Buy
Maxim sees potential for Opexa's Tcelna as adjuvant to stem cell transplant
Maxim analyst Jason McCarthy noted that a study published this morning in The Lancet recounts a phase 2 trial of immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis wherein 70% of patients achieved the primary endpoint of MS activity-free survival at three years post transplant. McCarthy noted that he we now sees the potential for Opexa Therapeutics' Tcelna as an adjuvant to stem cell transplant to extend already long disease-free responses, adding "if we see it, we believe Opexa and big pharma could see the potential too." The firm has a Buy rating on Opexa shares, which are up 15% near midday.
10/28/16
AGIS
10/28/16
DOWNGRADE
AGIS
Hold
Opexa Therapeutics downgraded to Hold from Buy at Aegis
Aegis downgraded Opexa Therapeutics to Hold after Tcelna trial failure.
10/31/16
MAXM
10/31/16
DOWNGRADE
MAXM
Hold
Opexa Therapeutics downgraded to Hold from Buy at Maxim
Maxim analyst Jason McCarthy downgraded Opexa Therapeutics to Hold from Buy on October 28, citing the failure of Tcelna, the company's T cell-based immunotherapy for the treatment of Secondary Progressive Multiple Sclerosis, in a phase 2b study. The analyst said he thinks it is unlikely that Tcelna can move forward in MS, though noted that there are other programs, such as NMO, that Opexa has that may be able to move forward.

TODAY'S FREE FLY STORIES

10:15
09/21/17
09/21
10:15
09/21/17
10:15
General news
U.S. leading index rose 0.4% to 128.8 in August »

U.S. leading index rose…

10:15
09/21/17
09/21
10:15
09/21/17
10:15
General news
Breaking General news story  »

Week of 9/15 EIA Natural…

EEM

MSCI Emerging Markets Index

$45.63

-0.01 (-0.02%)

10:10
09/21/17
09/21
10:10
09/21/17
10:10
Options
Friday the 13th put buyer in iShares Emerging Markets Fund »

Friday the 13th put buyer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMBA

Ambarella

$46.15

-0.29 (-0.62%)

, GOOG

Alphabet

$931.58

9.77 (1.06%)

10:06
09/21/17
09/21
10:06
09/21/17
10:06
Recommendations
Ambarella, Alphabet, Alphabet Class A analyst commentary  »

Smart doorbell business…

AMBA

Ambarella

$46.15

-0.29 (-0.62%)

GOOG

Alphabet

$931.58

9.77 (1.06%)

GOOGL

Alphabet Class A

$947.54

10.68 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

  • 22

    Oct

  • 29

    Nov

CCC

Calgon Carbon

$21.33

8.125 (61.55%)

10:06
09/21/17
09/21
10:06
09/21/17
10:06
Downgrade
Calgon Carbon rating change  »

Calgon Carbon downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASMB

Assembly Biosciences

$30.49

-0.43 (-1.39%)

10:05
09/21/17
09/21
10:05
09/21/17
10:05
Conference/Events
Assembly Biosciences management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

AR

Antero Resources

$20.34

0.04 (0.20%)

10:03
09/21/17
09/21
10:03
09/21/17
10:03
Downgrade
Antero Resources rating change  »

Follow-up: Antero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMP

Oasis Midstream Partners

, OAS

Oasis Petroleum

$8.68

-0.23 (-2.58%)

10:03
09/21/17
09/21
10:03
09/21/17
10:03
Syndicate
Breaking Syndicate news story on Oasis Midstream Partners, Oasis Petroleum »

Oasis Midstream Partners…

OMP

Oasis Midstream Partners

OAS

Oasis Petroleum

$8.68

-0.23 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 21

    Sep

10:02
09/21/17
09/21
10:02
09/21/17
10:02
General news
Leading Indicators data reported »

August Leading Indicators…

GLD

SPDR Gold Trust

$122.83

-0.79 (-0.64%)

10:01
09/21/17
09/21
10:01
09/21/17
10:01
Options
One-day put seller in SPDR Gold Fund »

One-day put seller in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
09/21/17
09/21
10:00
09/21/17
10:00
General news
Fed funds futures are little changed inside a very narrow trading ranges »

Fed funds futures are…

ARI

Apollo Commercial

$18.35

0.065 (0.36%)

09:59
09/21/17
09/21
09:59
09/21/17
09:59
Conference/Events
Apollo Commercial management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ALB

Albemarle

$135.68

-0.405 (-0.30%)

09:59
09/21/17
09/21
09:59
09/21/17
09:59
Conference/Events
Albemarle management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

AFSI

AmTrust

$12.90

0.01 (0.08%)

09:57
09/21/17
09/21
09:57
09/21/17
09:57
Conference/Events
AmTrust management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AAPL

Apple

$156.07

-2.66 (-1.68%)

09:57
09/21/17
09/21
09:57
09/21/17
09:57
Technical Analysis
Technical View: Apple edges below uptrend support line »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AR

Antero Resources

$20.21

-0.09 (-0.44%)

09:56
09/21/17
09/21
09:56
09/21/17
09:56
Downgrade
Antero Resources rating change  »

Antero Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$50.66

0.12 (0.24%)

09:55
09/21/17
09/21
09:55
09/21/17
09:55
Hot Stocks
Alkermes CEO highlights study showing opioids reduce life expectancy »

Alkermes CEO Richard Pops…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

APC

Anadarko

$47.29

2.48 (5.53%)

, PEG

PSEG

$45.88

0.645 (1.43%)

09:55
09/21/17
09/21
09:55
09/21/17
09:55
Options
Early notable gainers among liquid option names on September 21st »

Notable gainers among…

APC

Anadarko

$47.29

2.48 (5.53%)

PEG

PSEG

$45.88

0.645 (1.43%)

SLG

SL Green Realty

$98.99

1.27 (1.30%)

TSS

TSYS

$68.28

0.83 (1.23%)

CF

CF Industries

$35.50

0.31 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 27

    Sep

  • 05

    Nov

AMD

AMD

$13.74

0.62 (4.73%)

09:53
09/21/17
09/21
09:53
09/21/17
09:53
Options
Flurry of activity in AMD calls early-Thursday »

Flurry of activity in AMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMP

Oasis Midstream Partners

, OAS

Oasis Petroleum

$8.83

-0.085 (-0.95%)

09:51
09/21/17
09/21
09:51
09/21/17
09:51
Syndicate
Breaking Syndicate news story on Oasis Midstream Partners, Oasis Petroleum »

Oasis Midstream Partners…

OMP

Oasis Midstream Partners

OAS

Oasis Petroleum

$8.83

-0.085 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 21

    Sep

KEG

Key Energy

$12.59

-0.05 (-0.40%)

09:50
09/21/17
09/21
09:50
09/21/17
09:50
Initiation
Key Energy initiated  »

Key Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXPE

Expedia

$143.01

1.54 (1.09%)

, GOOG

Alphabet

$931.58

9.77 (1.06%)

09:49
09/21/17
09/21
09:49
09/21/17
09:49
Periodicals
Expedia CEO says HomeAway unit profit goal may need shifting, Skift reports »

Expedia (EXPE) CEO Mark…

EXPE

Expedia

$143.01

1.54 (1.09%)

GOOG

Alphabet

$931.58

9.77 (1.06%)

GOOGL

Alphabet Class A

$947.54

10.68 (1.14%)

AMZN

Amazon.com

$973.21

3.35 (0.35%)

MSFT

Microsoft

$74.94

-0.5 (-0.66%)

AAPL

Apple

$156.07

-2.66 (-1.68%)

FB

Facebook

$172.17

-0.35 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 02

    Oct

  • 22

    Oct

  • 29

    Nov

HON

Honeywell

$139.09

0.4 (0.29%)

09:48
09/21/17
09/21
09:48
09/21/17
09:48
Recommendations
Honeywell could rally over 14% on portfolio shakeup, says Deutsche Bank »

Honeywell is expected to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBUU

Malibu Boats

$28.53

0.2 (0.71%)

09:48
09/21/17
09/21
09:48
09/21/17
09:48
Periodicals
Breaking Periodicals news story on Malibu Boats »

Malibu Boats mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$10.66

-0.31 (-2.83%)

09:47
09/21/17
09/21
09:47
09/21/17
09:47
Recommendations
GoPro analyst commentary  »

GoPro unit and earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.